BiggsWS, DemuthRH. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician, 2011; 84:918–924.
2.
Direkvand-MoghadamA, et al.Epidemiology of premenstrual syndrome (PMS)—A systematic review and meta-analysis study. J Clin Diagn Res, 2014; 8:106–109.
3.
MortolaJF, et al.Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: The calendar of premenstrual experiences. Obstet Gynecol, 1990; 76:302–307.
4.
Bertone-JohnsonER, et al.Association of premenstrual syndrome with blood pressure in young adult women. J Womens Health (Larchmt), 2016; 25:1122–1128.
5.
KannelWB. Hypertension: Reflections on risks and prognostication. Med Clin North Am, 2009; 93:541–558, Table of Contents.
6.
KannelWB. Risk stratification in hypertension: New insights from the Framingham Study. Am J Hypertens, 2000; 13(Pt 2):3s–10s.
7.
Bertone-JohnsonER, et al.Premenstrual syndrome and subsequent risk of hypertension in a prospective study. Am J Epidemiol, 2015; 182:1000–1009.
8.
Bertone-JohnsonER, et al.Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod, 2014; 29:1987–1994.
9.
TalbottEO, et al.The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2004; 89:6061–6067.
10.
PopeJE, AndersonJJ, FelsonDT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med, 1993; 153:477–484.
